Clinical experience with inactivated, virosomal influenza vaccine
Authors:
- I.A. de BruijnIBI.A. de Bruijn
- J. NautaJNJ. Nauta
- W.C.M. CramerWCW.C.M. Cramer
- L. GerezLGL. Gerez
- A.M. PalacheAPA.M. Palache
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysisVaccine, 2004
- Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the ElderlyNew England Journal of Medicine, 2003
- Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activityVaccine, 2003
- Immunity to influenza in the elderlyVaccine, 2000
- Impact of Respiratory Virus Infections on Persons With Chronic Underlying ConditionsJAMA, 2000
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of internal medicine (1960), 1998
- A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humansVaccine, 1996
- Immunogenicity of new virosome influenza vaccine in elderly peopleThe Lancet, 1994
- Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trialVaccine, 1994
- Antibody induction by influenza vaccines in the elderly: a review of the literatureVaccine, 1989